MIST · Milestone Pharmaceuticals Inc
United States · RS rating 6 · As of 2026-10-14
| Price | 0.79 USD |
|---|---|
| 1-day change | +2.9% |
| RS rating (overall / 1M / 3M / 12M) | 6 / 16 / 9 / 11 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 18 / 5 / 31 |
| Industry group (rank) | Medical-Ethical Drugs (91) |
| EPS growth Q/Q | -5.0% |
| Sales growth Q/Q | -84.6% |
| Distance from 52-week high | +73.3% |
| Market cap (USD) | $220.0M |